(15008931), J. S. W., (15054769), H. T., (15054772), J. A. E., (15054775), N. M. A., (15054778), B. S., (15054781), H. B., . . . (14932995), M. A. D. (2025). Supplementary Figure S1 from Clinical Features Associated with Outcomes and Biomarker Analysis of Dabrafenib plus Trametinib Treatment in Patients with BRAF-Mutant Melanoma Brain Metastases.
शिकागो शैली (17वां संस्करण) प्रशस्ति पत्र(15008931), James S. Wilmott, et al. Supplementary Figure S1 from Clinical Features Associated with Outcomes and Biomarker Analysis of Dabrafenib Plus Trametinib Treatment in Patients with BRAF-Mutant Melanoma Brain Metastases. 2025.
एमएलए (9वां संस्करण) प्रशस्ति पत्र(15008931), James S. Wilmott, et al. Supplementary Figure S1 from Clinical Features Associated with Outcomes and Biomarker Analysis of Dabrafenib Plus Trametinib Treatment in Patients with BRAF-Mutant Melanoma Brain Metastases. 2025.